ceramide monohexoside

Known as: monohexosylceramide 
 

Topic mentions per year

Topic mentions per year

1965-2017
02419652017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
BACKGROUND Sphingolipids, including sphingosine-1-phosphate (S1P) and ceramide, have emerged as key regulatory molecules that… (More)
Is this relevant?
2015
2015
Insulin resistance is a homeorhetic adaptation to parturition in dairy cows transitioning from late pregnancy to early lactation… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2015
2015
Gaucher disease (GD) is a rare genetic disorder that arises from lipid species, especially monohexosylceramide (MHC… (More)
  • figure 1
  • table 1
  • table 2
  • figure 3
  • figure 4
Is this relevant?
2013
2013
BACKGROUND Mutations in the gene coding for glucocerebrosidase (GBA), which metabolizes glucosylceramide (a monohexosylceramide… (More)
  • figure 1
  • table 1
  • table 2
Is this relevant?
2007
2007
The lipid composition and molecular species of phospholipids were examined in the brain of a patient with Zellweger syndrome (ZS… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Sphingolipids are major components of the plasma membrane, tonoplast, and other endomembranes of plant cells. Previous… (More)
Is this relevant?
2002
2002
The interrelationships among sphingolipid structure, membrane curvature, and glycosphingolipid transmembrane distribution remain… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
A major ceramide monohexoside (CMH) was purified from lipidic extracts of Cryptococcus neoformans. This molecule was analyzed by… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1997
1997
In this study the comparative TLC immunostaining investigation of neutral GSLs and gangliosides from human skeletal and heart… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
1973
Highly Cited
1973
Treatment of erythrocytes with galactose oxidase (EC 1. I .3.9) followed by reduction with tritiated sodium borohydride (NaB3H… (More)
  • figure 2
  • figure 1
  • table I
  • table III
  • figure 3
Is this relevant?